Monopar Therapeutics (MNPR) Prepaid Assets: 2016-2020
Historic Prepaid Assets for Monopar Therapeutics (MNPR) over the last 3 years, with Sep 2020 value amounting to $104,550.
- Monopar Therapeutics' Prepaid Assets rose 23.18% to $104,550 in Q3 2020 from the same period last year, while for Sep 2020 it was $104,550, marking a year-over-year increase of 23.18%. This contributed to the annual value of $15,711 for FY2019, which is 8.23% up from last year.
- Latest data reveals that Monopar Therapeutics reported Prepaid Assets of $104,550 as of Q3 2020, which was down 43.00% from $183,416 recorded in Q2 2020.
- Over the past 5 years, Monopar Therapeutics' Prepaid Assets peaked at $269,512 during Q3 2018, and registered a low of $14,516 during Q4 2018.
- For the 3-year period, Monopar Therapeutics' Prepaid Assets averaged around $126,882, with its median value being $104,550 (2020).
- As far as peak fluctuations go, Monopar Therapeutics' Prepaid Assets spiked by 561.92% in 2017, and later slumped by 90.28% in 2018.
- Quarterly analysis of 5 years shows Monopar Therapeutics' Prepaid Assets stood at $22,562 in 2016, then spiked by 561.92% to $149,342 in 2017, then slumped by 90.28% to $14,516 in 2018, then rose by 8.23% to $15,711 in 2019, then climbed by 23.18% to $104,550 in 2020.
- Its Prepaid Assets was $104,550 in Q3 2020, compared to $183,416 in Q2 2020 and $124,194 in Q1 2020.